NCT03913624

Brief Summary

A Randomized Clinical Trial (RCT) was conducted to determine the effects of two neuromuscular electrical stimulation protocols with different stimulation frequencies on motor recovery in older adults with spastic hemiparesis after a stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jul 2009

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 12, 2019

Completed
Last Updated

April 12, 2019

Status Verified

April 1, 2019

Enrollment Period

5.2 years

First QC Date

March 9, 2019

Last Update Submit

April 9, 2019

Conditions

Keywords

RehabilitationElectric stimulationUpper limbAging

Outcome Measures

Primary Outcomes (4)

  • Change in range of motion

    A universal goniometer was used to measure the resting angle, active extension and passive extension of the wrist. A special JAMAR finger goniometer was used to evaluate the resting angle and active extension of the metacarpophalangeal joints of the fingers.

    The groups were assessed at baseline and 12 weeks post-intervention.

  • Change in dynamometric strength

    The grip strength was assessed by means of a JAMAR hydraulic hand dynamometer and the pinch strength using the JAMAR hydraulic pinch gauge. Unit of measurement was kgf. Three repetitions were done in both evaluations, taking the highest value and leaving a resting period of 1 minute between them.

    The groups were assessed at baseline and 12 weeks post-intervention.

  • Change in muscle tone

    Hypertonia of the finger and wrist flexors was measured using the modified Ashworth scale (MAS). MAS was used to categorize the severity of muscle tone by judging resistance to passive movement. It is a 6-point scale (0, 1, 1+ 2, 3, and 4) that ranges from 1 (=no increase in tone) to 4 (=limb rigid in flexion or extension). The assessment was started 5 minutes after laying the subject down in the supine position and using a single passive movement to evaluate each muscle group.

    The groups were assessed at baseline and 12 weeks post-intervention.

  • Change in functional motor ability

    Manual dexterity was assessed by Box and block test.

    The groups were assessed at baseline and 12 weeks post-intervention.

Secondary Outcomes (6)

  • Change in the mean electromyographic (EMG) amplitude

    The groups were assessed at baseline and 12 weeks post-intervention.

  • Change in the peak EMG amplitude

    The groups were assessed at baseline and 12 weeks post-intervention.

  • Change in the antagonist co-activation ratio

    The groups were assessed at baseline and 12 weeks post-intervention.

  • Change in kinaesthetic sensation

    The groups were assessed at baseline and 12 weeks post-intervention.

  • Change in activities of daily living

    The groups were assessed at baseline and 12 weeks post-intervention.

  • +1 more secondary outcomes

Other Outcomes (1)

  • Intervention costs

    Intervention costs were recorded from the baseline to 12 weeks.

Study Arms (3)

50 Hz NMES group

EXPERIMENTAL

Neuromuscular electrical stimulation (NMES) was applied on wrist and finger extensors for 30 minutes, 3 sessions per week for 8 weeks. The main electrostimulation parameters consisted of low-frequency current, a stimulation frequency of 50 Hz, symmetrical rectangular biphasic wave, and pulse duration of 300 μs.

Other: Neuromuscular electrical stimulation

35 Hz NMES group

EXPERIMENTAL

Neuromuscular electrical stimulation (NMES) was applied on wrist and finger extensors for 30 minutes, 3 sessions per week for 8 weeks. The main electrostimulation parameters consisted of low-frequency current, a stimulation frequency of 35 Hz, symmetrical rectangular biphasic wave, and pulse duration of 300 μs.

Other: Neuromuscular electrical stimulation

Control group

NO INTERVENTION

Conventional treatment

Interventions

35 Hz NMES group50 Hz NMES group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 60 years
  • Post-stroke spastic hemiparesis
  • Mild-moderate hand impairment
  • A score ≤ 3 on the modified Ashworth scale for wrist and finger flexors
  • Active wrist extension ≥ 5º from the resting position
  • Wrist extension response to stimulation
  • Post-stroke period \< 18 months
  • Clinical stability
  • Mini-Mental State Examination score ≥ 23

You may not qualify if:

  • Previous hemiparesis due to stroke
  • Dermatological reactions with the application of stimulation
  • Significant sensory deficits in the affected arm
  • Previous musculoskeletal problems of the hand
  • Treatment with the botulin toxin
  • Anti-spastic medication usage
  • Cardiac pacemaker, implanted electronic device, or metal implants in the affected arm
  • Complex regional pain syndrome
  • Severe aphasia, history of epileptic seizures, psychiatric disorder or important alterations of behavior
  • Severe visual impairment
  • Any comorbid neurological disease
  • Important deformity or obesity that affects the application of the NMES
  • Potentially fatal cardiac arrhythmia or another decompensated heart disease
  • Systemic infectious process, cancer or another terminal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Doctor Peset University Hospital

Valencia, 46017, Spain

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Trinidad Sentandreu Mañó, PT, PhD

    University of Valencia

    PRINCIPAL INVESTIGATOR
  • J. Ricardo Salom Terrádez, MD, PhD

    Doctor Peset University Hospital

    STUDY CHAIR
  • J. Manuel Tomas, PhD

    University of Valencia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 9, 2019

First Posted

April 12, 2019

Study Start

July 1, 2009

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

April 12, 2019

Record last verified: 2019-04

Locations